COX-2 inhibitors and cardiovascular risk - Point and counterpoint

被引：2

作者：

Mandell, BF ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Cleveland Clin Journal Med, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2001年 / 68卷 / 11期

关键词：

D O I：

10.3949/ccjm.68.11.957

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：957 / 960

页数：4

共 50 条

[21] COX-2 inhibitors and the thrombotic risk
Schroer, Karsten
Weber, Artur-Aron
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) : 391 - 392
[22] COX-2 inhibitors, other NSAIDs, and cardiovascular risk - The seduction of common sense
Graham, David J.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (13): : 1653 - 1656
[23] COX-2 inhibitors and cardiovascular risk - Inferences based on biology and clinical studies
Marwali, Muhammad R.
Mehta, Jawahar L.
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) : 401 - 406
[24] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
Mukherjee, D
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
[25] Cyclooxygenase-2: where are we in 2003? Cardiovascular risk and COX-2 inhibitors
Mukherjee, D
Topol, EJ
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (01) : 8 - 11
[26] COX-2 inhibitors may raise cardiovascular risks
不详
PHYSICIAN AND SPORTSMEDICINE, 1999, 27 (03): : 15 - 15
[27] COX-2 inhibitors and risk of heart failure
Kammerl, MC
Debler, J
Riegger, GA
Krämer, BK
LANCET, 2004, 364 (9444): : 1486 - 1487
[28] COX-2 inhibitors differ in TE risk
Reactions Weekly, 2003, 982 (1) : 4 - 4
[29] Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs - COX-2 inhibitors were thought of as a safe option
Lewis, MR
Kay, D
BRITISH MEDICAL JOURNAL, 2005, 331 (7530): : 1474 - 1474
[30] COX-2 inhibitors and cardiovascular risk - We defend our data and suggest caution
Mukherjee, D
Nissen, SE
Topol, EJ
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (11) : 963 - 964

← 1 2 3 4 5 →